Merck Investigator Studies Program - A cross-sectional observational study on the aetiology of recurrent acute otitis media in Western Australia in the PCV13-era: the WALACE study (Western Australian Aetiology of Acute and Chronic Ear Disease)

Project Details

StatusActive
Effective start/end date23/09/2123/09/23

Funding

  • Merck, Sharp & Dohme Australia: A$126,556.00
  • Merck, Sharp & Dohme Australia: A$105,464.00
  • Merck, Sharp & Dohme Australia: A$105,464.00
  • Merck, Sharp & Dohme Australia: A$84,371.00